Digital health startup Rimidi, formerly known as Rimidi Diabetes, has made its expanded mission official on the heels of a $6.575 million funding round. The capital came from new investors, pharmaceutical giant Eli Lilly and Company and Turner Investments, as well as existing investors Cox Enterprises, Village Capital, The Jump Fund and JAMB Global. Prior […]